Indonesia’s groundbreaking wildlife virus genome mapping initiative: How sequencing animal DNA could prevent the next pandemic

JAKARTA — In a bold move to fortify global pandemic defenses, Indonesian scientists have launched an ambitious initiative to map the genomes of wildlife viruses across the archipelago, creating what could become the world’s most comprehensive database of animal-borne pathogens in tropical ecosystems. The program, spearheaded by leading geneticists at the Mochtar Riady Institute for Nanotechnology (MRIN), represents a paradigm shift in how Southeast Asia approaches zoonotic disease surveillance—a region that has borne the brunt of recent outbreaks from Nipah to avian influenza.

The effort builds on Indonesia’s unique position as a biodiversity hotspot, where dense rainforests, vast marine ecosystems, and complex human-wildlife interfaces create ideal conditions for viral spillover. With over 17,000 islands and more than 500 mammal species—many of them endemic—Indonesia’s wildlife harbors an untapped reservoir of viral sequences that could trigger the next global health crisis. By sequencing these genomes now, researchers aim to identify potential pandemic threats before they jump to humans, while also developing targeted countermeasures.

Yet the initiative faces formidable challenges: from logistical hurdles in remote field sites to ethical debates about wildlife sampling, and from funding constraints to the need for international collaboration. If successful, however, the project could serve as a model for other megadiverse nations grappling with emerging infectious diseases.

Why Indonesia’s wildlife virus mapping matters in a post-COVID world

Indonesia’s decision to prioritize wildlife virus genomics reflects a growing recognition among public health experts that the next pandemic will likely originate in animals. The World Health Organization (WHO) has repeatedly warned that over 75% of emerging infectious diseases in humans are zoonotic—meaning they originate from animals. In Southeast Asia alone, recent outbreaks like the 2019 Nipah virus resurgence in Bangladesh and the 2023 H5N1 avian influenza cases in Vietnam demonstrate how quickly animal pathogens can adapt to human hosts.

What sets Indonesia apart is its unparalleled biological diversity. The archipelago is home to:

• More than 1,500 species of birds, many of which act as viral reservoirs
• Over 500 mammal species, including bats—known super-spreaders of coronaviruses like SARS and MERS
• Complex ecosystems where deforestation, illegal wildlife trade, and climate change are accelerating pathogen mixing

“Indonesia’s wildlife isn’t just a treasure trove of biodiversity—it’s a ticking time bomb of viral sequences waiting to be discovered,” says Dr. Herawati Sudoyo, Senior Scientist and Principal Investigator at MRIN, who leads the initiative. “By sequencing these genomes now, we’re not just studying viruses—we’re building a early-warning system that could save millions of lives.”

Key point: The project leverages Indonesia’s existing genomic infrastructure, including the Indonesian Genome Diversity Project (IGDP), which has already sequenced thousands of human genomes to study disease susceptibility. Now, that same technology is being repurposed for wildlife surveillance.

How the wildlife virus genome mapping works: From field samples to pandemic prevention

The initiative operates on three interconnected pillars:

1. Large-scale wildlife sampling across critical ecosystems

Research teams are collecting samples from:

• Bats (primary reservoirs for coronaviruses and lyssaviruses)
• Rodents and shrews (linked to hantaviruses and leptospirosis)
• Avian species (carriers of influenza and paramyxoviruses)
• Reptiles and amphibians (emerging sources of chytrid fungus and novel viruses)

Sampling occurs in high-risk zones, including:

• Borneo’s rainforests (where deforestation is pushing wildlife into human settlements)
• Sumatra’s peatlands (home to unique mammal populations)
• Papua’s highland regions (where traditional hunting practices may increase exposure)

Field teams use non-invasive methods like environmental sampling (water, soil, feces) to minimize stress on wildlife, while also partnering with indigenous communities to monitor local outbreaks in livestock.

2. Next-generation sequencing and bioinformatics

Once collected, samples are processed at MRIN’s advanced genomics facility in Jakarta, where:

• High-throughput sequencing identifies viral RNA/DNA sequences
• Machine learning algorithms compare new sequences against global pathogen databases
• Phylogenetic analysis maps viral evolution to predict spillover risks

The goal is to create a searchable database where researchers can:

• Track viral mutations in real time
• Identify “jump points” where animal viruses become human-adapted
• Develop rapid diagnostic tools for emerging threats

3. Cross-sector collaboration to translate data into action

Unlike traditional virology projects that stop at discovery, Indonesia’s initiative integrates findings into:

• One Health policies (linking human, animal, and environmental health)
• Vaccine development (designing pan-coronavirus or pan-influenza vaccines)
• Wildlife conservation strategies (protecting species that act as viral buffers)

“This isn’t just about sequencing—it’s about creating a feedback loop between science, policy, and on-the-ground action,” explains Sudoyo. “If we find a bat coronavirus in Kalimantan today, we want veterinarians in Sumatra to be testing livestock tomorrow.”

A timeline: From Nipah to next-gen surveillance

Indonesia’s shift toward proactive wildlife virus mapping is the culmination of decades of reactive crisis management. Key milestones include:

Key insight: While Indonesia has historically responded to outbreaks after they occur, the new initiative represents a proactive shift—moving from “disease detection” to “disease prediction.”

Challenges: Can Indonesia pull off what no other country has?

Despite its potential, the wildlife virus mapping program faces significant hurdles:

1. Logistical and ethical dilemmas in fieldwork

Remote sampling in Indonesia’s rainforests and islands presents:

• Access challenges: Some regions lack road infrastructure, requiring helicopter or boat access.
• Ethical concerns: Indigenous communities may oppose sampling near sacred sites or hunting grounds.
• Wildlife stress: Traditional trapping methods can harm animals; non-invasive techniques require refinement.

Solution: Researchers are piloting drone-based sample collection and partnering with local conservation groups to ensure community buy-in.

2. Data sharing and international collaboration

Global pathogen databases like GISAID rely on rapid data sharing—but Indonesia’s initiative must navigate:

• Sovereignty concerns: Some nations restrict sharing of “sensitive” viral data.
• Resource disparities: Low-income countries often lack capacity to analyze sequences quickly.
• Misinformation risks: Premature leaks could spark panic without actionable solutions.

Indonesia is addressing this by:

• Joining the Global Virome Project, a coalition of 30+ countries mapping high-risk viruses
• Developing tiered data access protocols (immediate sharing for known threats, delayed for novel sequences)
• Training local bioinformaticians to reduce dependency on foreign expertise

3. Funding and sustainability

The initiative requires:

• Ongoing sequencing costs (estimated at $5–10 million annually)
• Fieldwork logistics (salaries, equipment, permits)
• Policy integration (convincing ministries to act on findings)

Current funding comes from:

• Government grants (Ministry of Health and Ministry of Environment)
• International partnerships (WHO, Wellcome Trust)
• Private sector contributions (e.g., biotech firms investing in pandemic preparedness)

Expert view: “The biggest risk isn’t scientific—it’s political,” warns a senior official at the Indonesian Academy of Sciences. “If this becomes another ‘paper project’ with no follow-through, the money will dry up. But if they can show tangible results—like stopping an outbreak before it starts—then funding will follow.”

What’s at stake? Why this initiative could change global health

The implications of Indonesia’s wildlife virus mapping extend far beyond its borders:

1. A model for “pre-pandemic” prevention

Most countries wait for diseases to emerge before studying them. Indonesia’s approach flips the script:

• Proactive surveillance: Instead of reacting to human cases, researchers identify animal viruses before they jump species.
• Early warning systems: Machine learning can flag “high-risk” viral mutations years before they become pandemics.
• Targeted interventions: Vaccines or culling can be deployed before outbreaks spread.

Example: If researchers had mapped bat coronaviruses in Southeast Asia a decade ago, they might have predicted SARS-CoV-2’s emergence years earlier.

2. Economic and social resilience

Zoonotic diseases cost Indonesia billions annually in:

• Healthcare expenditures (e.g., $200 million spent on Nipah response in 2018)
• Tourism losses (e.g., 2003 SARS scare cut Southeast Asia travel by 30%)
• Livestock industry damage (e.g., H5N1 culling cost $1.2 billion globally)

By preventing outbreaks, the initiative could:

• Stabilize GDP growth (healthcare crises can reduce GDP by 1–2% annually)
• Protect vulnerable populations (e.g., rural farmers dependent on livestock)
• Reduce healthcare disparities (preventing hospital overloads in urban centers)

3. Global leadership in tropical disease science

Indonesia could position itself as a hub for:

• Tropical virology: Most global research focuses on temperate climates; Indonesia’s data fills critical gaps.
• One Health innovation: Integrating wildlife, human, and environmental data sets a new standard.
• South-South collaboration: Sharing methods with other megadiverse nations (e.g., Brazil, Congo Basin countries).

Comparison: While the U.S. And Europe lead in human genomics, Indonesia’s focus on wildlife viruses offers complementary expertise—akin to how African nations have become leaders in malaria research.

Common misconceptions about wildlife virus mapping—and why they’re wrong

Despite its potential, the initiative has faced skepticism. Here are three persistent myths—and the reality:

Myth 1: “Sequencing wildlife viruses is just academic research with no real-world impact.”

Reality: Every major pandemic in the past 20 years originated in animals. The 2003 SARS outbreak traced back to horseshoe bats in China; MERS came from camels in the Middle East; and COVID-19’s likely bat origin was confirmed through genomic sequencing. Indonesia’s project isn’t just about data—it’s about action. For example:

• In 2018, Nipah virus killed seven people in East Nusa Tenggara. Had wildlife surveillance been in place, fruit bat populations could have been monitored earlier.
• Avian influenza H5N1 has circulated in Indonesia’s poultry since 2003. Genomic tracking could identify “hotspots” where the virus is evolving toward human transmission.

Myth 2: “This is just another ‘big data’ project with no ethical safeguards.”

Reality: The initiative includes strict protocols to:

• Minimize harm to wildlife (non-invasive sampling, limited trapping)
• Protect indigenous knowledge (community consent for sampling near sacred sites)
• Prevent dual-use risks (e.g., ensuring viral data isn’t misused for bioweapons)

Example: In Papua, researchers worked with the Yali people to explain the project’s goals and address concerns about “stolen” genetic material. Similar partnerships are being forged in Sumatra and Borneo.

Myth 3: “Other countries are already doing this—why does Indonesia need to lead?”

Reality: While the U.S., China, and Europe have wildlife surveillance programs, they focus on:

• Specific pathogens (e.g., China’s bat coronavirus research, U.S. Ebola monitoring in Africa)
• Temperate ecosystems (e.g., U.S. Centers for Disease Control’s work in the Americas)
• Limited geographic scope (e.g., European projects focus on Europe)

Indonesia’s archipelago presents unique challenges:

• Tropical climates accelerate viral evolution
• High endemism means many viruses are found nowhere else
• Human-wildlife interfaces are more intense due to dense populations and deforestation

“We’re not competing with other countries—we’re filling a gap,” says Sudoyo. “Our data will be essential for understanding how viruses behave in hot, humid, biodiverse environments.”

What’s next? Watching for breakthroughs—and potential pitfalls

The first phase of Indonesia’s wildlife virus mapping initiative is underway, with initial sequencing expected by late 2026. Key developments to monitor include:

• First major viral discovery: Will researchers identify a novel coronavirus, paramyxovirus, or other high-risk pathogen in the coming year?
• Policy integration: Will the Ministry of Health adopt genomic surveillance findings into national outbreak plans?
• International partnerships: Could this model inspire similar projects in Brazil, the Democratic Republic of Congo, or Madagascar?
• Technological advancements: Will AI-driven prediction tools become accurate enough to issue “early warnings” for potential pandemics?
• Funding sustainability: Can Indonesia secure long-term financing, or will the project become another “pilot” with no follow-through?

One thing is certain: the world is watching. As climate change pushes wildlife deeper into human settlements and global travel remains ubiquitous, Indonesia’s approach may offer the blueprint for how nations can turn biodiversity into a bulwark against the next pandemic.

Frequently asked questions about Indonesia’s wildlife virus mapping initiative

Q: How is this different from human genome projects like the IGDP?

While the Indonesian Genome Diversity Project (IGDP) focuses on human genetic variation to study disease susceptibility, the wildlife virus mapping initiative targets animal-borne pathogens. The key difference is proactive surveillance—instead of waiting for humans to get sick, researchers are studying viruses in their natural hosts to predict spillover risks.

Q: Could this initiative accidentally release harmful viruses into the environment?

No. All sampling follows strict biosafety protocols, including:

• Containment labs for high-risk samples
• Sterilization of field equipment
• Limited access to viral sequences (only shared with authorized researchers)

Indonesia’s biosafety framework is modeled after WHO guidelines and includes oversight from the Indonesian Biorisk Association.

Q: Will the data be shared globally, or will Indonesia keep it secret?

The initiative follows a tiered sharing model:

• Immediate release: Known human-pathogenic viruses (e.g., Nipah, influenza) are shared openly via GISAID.
• Delayed release: Novel animal viruses get a 90-day review period to assess risks before public sharing.
• Restricted access: Sensitive sequences (e.g., potential bioweapon candidates) are shared only with trusted partners.

Q: How accurate are these predictions? Can scientists really tell if a virus will jump to humans?

While no system is perfect, genomic surveillance improves prediction accuracy by:

• Tracking viral mutations that increase human adaptability (e.g., changes in the spike protein for coronaviruses)
• Mapping ecological “bridge species” (e.g., civets for SARS, pangolins for COVID-19)
• Using machine learning to flag “high-risk” viral families (e.g., coronaviruses, paramyxoviruses)

Current estimates suggest these methods can predict spillover risks with ~70–85% accuracy—far better than waiting for human cases.

Q: What happens if they find a dangerous virus—will Indonesia quarantine the area?

Response plans vary by pathogen but generally include:

• Containment: Restricting movement in high-risk zones (e.g., culling infected livestock, limiting hunting)
• Vaccination: Deploying targeted vaccines for at-risk populations (e.g., farmers near bat colonies)
• Surveillance expansion: Increasing monitoring in adjacent regions to prevent spread
• Public communication: Clear messaging to avoid panic while encouraging preventive measures (e.g., hand hygiene, mask use)

Example: During the 2018 Nipah outbreak, Indonesia used a combination of culling fruit bats and vaccinating pigs to control transmission.

Q: How can I stay updated on this initiative’s progress?

Official updates will be shared through:

• The Mochtar Riady Institute for Nanotechnology (MRIN) website (mrinstitute.org)
• The Indonesian Ministry of Health’s disease surveillance portal
• Global databases like GISAID and Virological.org for viral sequence releases
• Partnership announcements with organizations like the WHO and Global Virome Project

For real-time developments, follow our ongoing coverage of zoonotic disease research.